CompoAtlas

3M(TM) SoluPrep Nasal Antiseptic

Natural health product licensed in Canada

Licence holder
Solventum Canada Limited
NPN or DIN-HM
80088061
Status
Inactive licence
Licence date
29 August 2018
Revision date
Not provided
Form
Solution
Route of administration
Nasale
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Composé homopolymère de 1-éthényl-2-pyrrolidinone avec de l'iode

Source : Povidone-iode

5 %

Non-medicinal ingredients

Eau purifiée, Oxyde de lauramidopropylamine, Hydroxyde de sodium, Acide DL-malique, Stéareth-100, Phosphate de poly(oxyéthylène) (10) poly(oxypropylène) (5) cétyl éther, Acide lactique, Poly(quaternium-10), Xylitol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsminimum: 2 mL ; maximum: 4 mL1 day

Uses authorised in Canada

Helps reduce the risk of surgical site infections (SSIs) when used as part of a comprehensive preoperative protocol. Reduces bacterial counts in the nares, including Staphylococcus aureus, as a preventative measure to help decrease the risk of surgical site infections.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80088061

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line